Compounds > 2-chloro-n(6)cyclopentyladenosine

Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and mrs 1523

2-chloro-n(6)cyclopentyladenosine has been researched along with mrs 1523 in 4 studies

Compound Research Comparison

Studies (2-chloro-n(6)cyclopentyladenosine)	Trials (2-chloro-n(6)cyclopentyladenosine)	Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine)	Studies (mrs 1523)	Trials (mrs 1523)	Recent Studies (post-2010) (mrs 1523)
252	0	43	42	0	17

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barak, D; Biadatti, T; Chen, W; Gao, ZG; Jacobson, KA; Johnson, CR; Kim, SG; Kim, SK; Lee, K	1
Balas, N; Jacobson, KA; Nawrath, H; Safran, N; Shainberg, A; Shneyvays, V	1
Jacobson, K; Mamedova, L; Shainberg, A; Shneyvays, V; Zinman, T	1
Harst, A; Hinze, AV; Mayer, P; von Kügelgen, I	1

Other Studies

4 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and mrs 1523

Article	Year
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Journal of medicinal chemistry, 2002, Sep-26, Volume: 45, Issue:20 Topics: Adenosine; Animals; Binding, Competitive; CHO Cells; Cricetinae; Epoxy Compounds; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Models, Molecular; Mutation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Ribose; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship	2002
Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes. Molecular and cellular biochemistry, 2001, Volume: 217, Issue:1-2 Topics: Adenosine; Animals; Animals, Newborn; Cell Hypoxia; Cells, Cultured; L-Lactate Dehydrogenase; Microscopy, Electron; Myocardial Ischemia; Myocardium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyridines; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines	2001
Activation of A(3)adenosine receptor protects against doxorubicin-induced cardiotoxicity. Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:6 Topics: Adenosine; Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Calcium; Cells, Cultured; Doxorubicin; Electron Transport Complex IV; Heart; L-Lactate Dehydrogenase; Lipid Peroxidation; Mitochondria; Myocardium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyridines; Rats; Receptor, Adenosine A3; Receptors, Purinergic P1	2001
Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes. Journal of molecular and cellular cardiology, 2012, Volume: 53, Issue:5 Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Cell Proliferation; Cells, Cultured; Coronary Vessels; Early Growth Response Protein 1; Early Growth Response Protein 2; Early Growth Response Protein 3; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Orphan Nuclear Receptors; Pertussis Toxin; Platelet-Derived Growth Factor; Primary Cell Culture; Pyridines; Receptor, Adenosine A3; Transcriptional Activation	2012